American Society of Clinical Oncology

SHERPA: White

People

  1. Berger
    Berger
  2. Solit
    Solit
  3. Funt
    Funt
  4. Bajorin
    Bajorin
  5. Carlo
    Carlo
  6. Motzer
    Motzer
  7. Feldman
    Feldman
  8. Ladanyi
    Ladanyi
  9. Kris
    Kris
  10. Iyer
    Iyer

Groups

  1. Weinberg Fellows (582)
  2. Department of Medicine (562)
  3. Solid Tumor Oncology Division (539)
  4. GSK Faculty (267)
  5. Department of Pathology and Laboratory Medicine (253)
  6. Epidemiology and Biostatistics (241)
  7. Human Oncology and Pathogenesis Program (205)
  8. Biostatistics Service (203)
  9. Hematologic Malignancies, Division of (199)
  10. Genitourinary Oncology Service (196)
Search Within
  1. "Weinberg Fellows"
Formats
  1. Meeting Abstract (467)
  2. Journal Article (100)
  3. Review (6)
  4. Editorial (5)
  5. Correspondence (3)
  6. Guidelines (1)
Groups
  1. Weinberg Fellows (582)
  2. Department of Medicine (562)
  3. Solid Tumor Oncology Division (539)
  4. GSK Faculty (267)
  5. Department of Pathology and Laboratory Medicine (253)
  6. Epidemiology and Biostatistics (241)

More Groups

People
  1. Michael Berger (82)
  2. David Solit (73)
  3. Samuel Funt (72)
  4. Dean Bajorin (59)
  5. Maria Carlo (58)
  6. Robert Motzer (54)

More People

Years
  1. 2025 (11)
  2. 2024 (91)
  3. 2023 (68)
  4. 2022 (82)
  5. 2021 (50)
  6. 2020 (71)

More Years

Publications
  1. Journal of Clinical Oncology (524)
  2. JCO Precision Oncology (47)
  3. American Society of Clinical Oncology Educational Book (4)
  4. JCO Clinical Cancer Informatics (4)
  5. Journal of Oncology Practice (2)
  6. JCO Oncology Practice (1)

Results (582)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Guide to understanding and supporting international medical graduates in hematology/oncology by the ASCO International Medical Graduates Community of Practice
    Review

    Dizman, N.; Bakouny, Z.; Haykal, T.; Riano, I.; Desai, A.; Butt, A.; Basu, A.; Zhao, D.; Saad, E.; Saliby, R. M.; more...
    JCO Oncology Practice (2025)

    Fulltext@MSK | Save
  • Phase II trial of nivolumab plus doxorubicin, vinblastine, dacarbazine as frontline therapy in older adults with Hodgkin lymphoma
    Journal Article

    Torka, P.; Feldman, T.; Savage, K. J.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Capadona, C.; Subzwari, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Real-time monitoring in renal cell carcinoma with circulating tumor DNA: A step forward, but how far?
    Editorial

    Zengin, Z. B.; Kotecha, R. R.
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Quality of treatment selection for medicare beneficiaries with cancer
    Journal Article

    Mitchell, A. P.; Persaud, S.; Mishra Meza, A.; Fuchs, H. E.; De, P.; Tabatabai, S.; Chakraborty, N.; Dey, P.; Trivedi, N. U.; Mailankody, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Phase I trial of MCARH109, a G protein-coupled receptor class C group 5 member D (GPRC5D)-targeted chimeric antigen receptor T-cell therapy for multiple myeloma: An updated analysis
    Journal Article

    Jurgens, E. M.; Firestone, R. S.; Chaudhari, J.; Hosszu, K.; Devlin, S. M.; Shah, U. A.; Landa, J.; McAvoy, D. P.; Lesokhin, A. M.; Korde, N.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • A phase II study of agenT-797 (invariant natural killer T-cells), botensilimab (Fc-enhanced CTLA-4 inhibitor) and balstilimab (anti-PD-1) in patients with advanced, refractory gastroesophageal adenocarcinoma
    Meeting Abstract

    Cytryn, S. L.; Maron, S. B.; Janjigian, Y. Y.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Clinical landscape of cell free DNA alterations in patients with advanced biliary tract cancer treated with targeted therapies
    Meeting Abstract

    Thummalapalli, R.; Darmofal, M.; Seier, K.; Khalil, D. N.; Walch, H. S.; Shia, J.; Park, W.; El Dika, I. H.; Chatila, W. K.; Schultz, N.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Obesity and biliary tract cancers: Changing epidemiology
    Meeting Abstract

    Al Mahmasani, L.; Chou, J. F.; Capanu, M.; Srivastava, A.; Sigel, C. S.; Alsuwailem, R.; Berger, M. F.; Khalil, D. N.; Harding, J. J.; O'Reilly, E. M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Efficacy and safety of cabozantinib for advanced gastrointestinal (GI) neuroendocrine tumors (NET) after progression on prior therapy: Subgroup analysis of the phase 3 CABINET trial (Alliance A021602)
    Meeting Abstract

    Strosberg, J. R.; Zemla, T. J.; Geyer, S. M.; Knopp, M. V.; Behr, S.; Pulsipher, S.; Acoba, J. D.; Shergill, A.; Wolin, E. M.; Halfdanarson, T. R.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Molecular and clinical determinants of targeted therapy (TT) outcomes in biliary tract cancer (BTC): Analysis of a prospectively maintained next generation sequencing (NGS) biorepository
    Meeting Abstract

    Cowzer, D.; Walch, H. S.; Atri, P.; Shah, F.; Huq, R.; Khalil, D. N.; Park, W.; Yeh, R.; Do, R. K. G.; Basturk, O.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save